Niranjan J. Arachchi

Gordon Street
Footscray, VIC 3011, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Clinical outcomes of patients with two small hepatocellular carcinomas.

Clinical outcomes of patients with two small hepatocellular carcinomas.

Journal: World journal of hepatology

Published: April 25, 2021

Increasing prevalence of primary biliary cholangitis in Victoria, Australia.

Increasing prevalence of primary biliary cholangitis in Victoria, Australia.

Journal: Journal of gastroenterology and hepatology

Published: July 21, 2019

Promoting hospital and primary care collaboration for timely and effective care for chronic hepatitis B in western Melbourne.

Promoting hospital and primary care collaboration for timely and effective care for chronic hepatitis B in western Melbourne.

Journal: Australian health review : a publication of the Australian Hospital Association

Published: June 08, 2019

Retreatment with elbasvir, grazoprevir, sofosbuvir ± ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse.

Retreatment with elbasvir, grazoprevir, sofosbuvir ± ribavirin is effective for GT3 and GT1/4/6 HCV infection after relapse.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 03, 2019

Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.

Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.

Journal: The Medical journal of Australia

Published: April 08, 2018

Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study.

Sorafenib in the treatment of hepatocellular carcinoma: a multi-centre real-world study.

Journal: Scandinavian journal of gastroenterology

Published: May 11, 2016

Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma.

Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma.

Journal: Scandinavian journal of clinical and laboratory investigation

Published: November 10, 2015

Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.

Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed.

Journal: Hepatology (Baltimore, Md.)

Published: April 08, 2015

Circulating CD147 predicts mortality in advanced hepatocellular carcinoma.

Circulating CD147 predicts mortality in advanced hepatocellular carcinoma.

Journal: Journal of gastroenterology and hepatology

Published: February 23, 2015

Vitamin B₁₂ and its binding proteins in hepatocellular carcinoma and chronic liver diseases.

Vitamin B₁₂ and its binding proteins in hepatocellular carcinoma and chronic liver diseases.

Journal: Scandinavian journal of gastroenterology

Published: June 25, 2014

Hepatic macrophage activation predicts clinical decompensation in chronic liver disease.

Hepatic macrophage activation predicts clinical decompensation in chronic liver disease.

Journal: Gut

Published: February 28, 2013

Epidemiology of hepatitis B-associated hepatocellular carcinoma in Victoria.

Epidemiology of hepatitis B-associated hepatocellular carcinoma in Victoria.

Journal: Internal medicine journal

Published: September 25, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026